Skip to main content
Equibles
LUCY logo

LUCY · Innovative Eyewear Inc · Metrics

Track LUCY — free

Use LUCY with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LUCY.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.86 0.00 (-0.37%)
Rebalance outlook locked
Market Cap
$7.47M
Shares
8.61M
Volume · Oct 26 139.42K Avg daily vol (3M) 3.47M

LUCY metrics

65 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.79
Market cap
$7.47M

Price action

20 metrics
Price change (1W)
+9.8%
Price change (30D)
-9.4%
Price change (3M)
+33.2%
Price change (6M)
-17.4%
Price change (YTD)
-13.0%
Price change (1Y)
-51.6%
Trailing year
Price change (5Y)
—
52-week high
$1.85
52-week low
$0.65
Change from 52-week high
-53.1%
Change from 52-week low
+33.2%
Annualized volatility
126.6%
Annualized volatility (3M)
147.2%
Beta
2.0
RSI (14D)
49.5
Price vs SMA 50
-1.6%
Price vs SMA 200
-12.4%
Avg volume (3M)
3.47M
Relative volume
0.1
Average dollar volume
$3.82M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
8.61M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
2.2×
reciprocal yield 45.7%
P / book
1.1
reciprocal yield 92.4%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-103.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
22.8%
Operating margin
—
Trailing 12 months
Net margin
-225.3%
Gross profit (TTM)
$777,543
Operating profit (TTM)
—
Net income (TTM)
−$7.69M
Trailing 12 months
Diluted EPS (TTM)
$-1.15
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$1.65

Growth

11 metrics
Revenue growth YoY
+74.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$3.41M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+99.2%
Year over year · more shares
Revenue CAGR (3Y)
+59.2%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-111.4%
Return on assets
-102.9%
Debt / equity
—
Current ratio
12.1
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
8.9
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$2.46M
Latest balance sheet
Cash & equivalents
$2.46M
Total assets
$7.47M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$7.20M
Capital expenditures (TTM)
$72,513
R&D (TTM)
$526,790
SG&A (TTM)
—
Stock compensation (TTM)
$795,197
R&D / revenue
15.4%
Stock compensation / revenue
23.3%

Ownership (13F)

9 metrics
13F filers
15
13F filer change QoQ
+4
Institutional ownership
10.4%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
1.5%
Private-fund adviser ownership
0.5%
Active holders' share change QoQ
+35.7%
Holder tenure
4.5
Price vs estimated holder cost
-49.8%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.6%

Short interest

3 metrics
Short interest
1.7%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
33 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$27,472
Insider-sentiment score
24 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1808377 Visit website Investor relations